Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Multicenter Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab

Novartis Pharmaceuticals · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
antibodyvaccine
relapsing multiple sclerosis, covid-19, vaccine, ofatumumab, sars-cov2, antibody, open-label, observational
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 850558
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.